Charles River bags antibody discovery-focused Distribution Bio for $104M, signaling return to pre-pandemic buyout spree
Charles River Labs, one of the biggest CROs that specializes in preclinical research programs, has inked a new discovery pact as part of a string …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
